FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

FDA Skips Panel Review for Capricor Cell Therapy

FDA says there will be no advisory committee review of Capricor Therapeutics BLA for Deramiocel, the companys lead cell therapy candidate for treating...

latest-news-card-1
Human Drugs

CDER Acting Head Corrigan-Curay Leaving in July

CDER acting director Jacqueline Corrigan-Curay decides to retire and will leave her post next month.

latest-news-card-1
Medical Devices

GE Recalls Carestation Anesthesia Devices

GE HealthCare recalls certain Carestation anesthesia devices due to the risk that they may not provide effective ventilation in certain situations.

latest-news-card-1
Human Drugs

Bimagrumab Enhances Weight Loss: Study

New data from a Phase 2 study on Eli Lillys experimental bimagrumab showed that when combined with Novo Nordisk's Wegovy (semaglutide) it led to prese...

latest-news-card-1
Human Drugs

Guideline on Drug Stability Testing Released

FDA posts an International Council for Harmonization draft guideline entitled Stability Testing of Drug Substances and Drug Products Q1.

latest-news-card-1
Human Drugs

Inspections Help Prevent Drug Shortages: Study

A new study disputes previous assumptions about FDA inspections leading to more drug shortages at facilities receiving GMP citations.

latest-news-card-1
Human Drugs

Daiichi Sankyo Drug OKd for Lung Cancer

FDA approves a Daiichi Sankyo BLA for Datroway (datopotamab deruxtecan-dlnk) for certain adults with locally advanced or metastatic epidermal growth f...

latest-news-card-1
Human Drugs

Medline Issues Correction for Procedure Kits

Medline Industries recalls certain lots of its medical procedure kits that include recalled Medtronic Aortic Root Cannulas due to a potential safety r...

latest-news-card-1
Human Drugs

Dupixent Approved for Bullous Pemphigoid

FDA has approved Sanofi and Regenerons Dupixent (dupilumab) for treating adult patients with bullous pemphigoid that mainly affects the elderly with i...

latest-news-card-1
Human Drugs

Monjuvi Approved for Follicular Lymphoma

FDA approves Incytes Monjuvi (tafasitamab-cxix) in combination with lenalidomide and rituximab for treating adults with relapsed or refractory follicu...